Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Prognostic value of translocation 11;14 in...
Journal article

Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy

Authors

Mohyuddin GR; Chakraborty R; Calip GS; Ascha MS; Wang X; Rubinstein SM; Tuchman S; Costa L; Haaland B; Giri S

Journal

Blood Cancer Journal, Vol. 12, No. 12,

Publisher

Springer Nature

DOI

10.1038/s41408-022-00769-4

ISSN

2044-5385